GOV.UK
Improving early access to sickle cell and thalassaemia screening
Early access to sickle cell and thalassaemia screening and the early offer of prenatal diagnosis (PND) is important in giving women and couples time to consider their options.
antenatal screening
Sickle cell and thalassaemia screening handbook for antenatal laboratories updated
We’re pleased to announce the publication of an updated version of the antenatal laboratory handbook for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
Does age matter when thinking of NHS newborn screening programmes?
We have recently updated and published a one page summary for healthcare professionals explaining which newborn screening tests can be offered at different ages if any of these were initially missed.
Parents’ stories: personal experiences of sickle cell and thalassaemia screening
As part of a wider investigation into why women are tested late, we commissioned the UK Thalassaemia Society (UKTS) and Sickle Cell Society (SCS) to carry out face to face interviews with women and couples who had recent experience of the SCT programme.
Revamped sickle cell and thalassaemia ‘at risk’ leaflets published
I’m the Sickle Cell and Thalassaemia Screening Lead at Northampton General Hospital and Kettering General Hospital. For the past year I’ve been on secondment as national project lead for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
Hepatitis B in pregnant women: World Hepatitis Day
Today is World Hepatitis Day, which makes it the right time to highlight the work of the NHS Infectious Diseases in Pregnancy Screening (IDPS) Programme on hepatitis B.
Screening information updated to include change to hepatitis B vaccine for babies
We’ve updated our antenatal and newborn screening information for public and professionals following a change to the vaccination schedule for babies.
Fetal anomaly screening providers can sign up now for NIPT training
Back in November 2016 and March 2017 we published blog articles about the additional option of non-invasive prenatal testing (NIPT) to the fetal anomaly screening pathway.
Checks and audits to improve quality and reduce risks in sickle cell and thalassaemia screening
We have published new information that describes the checks and audits that are needed for the sickle cell and thalassaemia (SCT) screening pathway.
Guidance on supporting agency sonographers for fetal anomaly screening
If you work in ultrasound or radiology you will be well aware there’s a national shortage of trained staff. Many ultrasound departments rely on agency sonographers.